US 12,247,980 B2
Compositions, methods and kits for diagnosis of lung cancer
Paul Edward Kearney, Seattle, WA (US); Kenneth C. Fang, San Francisco, CA (US); Xiao-Jun Li, Bellevue, WA (US); Clive Hayward, Seattle, WA (US); and Douglas Spicer, Enumclaw, WA (US)
Assigned to Biodesix, Inc., Boulder, CO (US)
Filed by Biodesix, Inc., Boulder, CO (US)
Filed on Sep. 9, 2021, as Appl. No. 17/470,462.
Application 17/470,462 is a continuation of application No. 15/786,924, filed on Oct. 18, 2017, granted, now 11,913,957.
Application 15/786,924 is a continuation in part of application No. 15/051,153, filed on Feb. 23, 2016, granted, now 10,338,074.
Application 15/051,153 is a continuation of application No. 13/775,494, filed on Feb. 25, 2013, granted, now 9,304,137.
Application 13/775,494 is a continuation in part of application No. 13/724,823, filed on Dec. 21, 2012, granted, now 9,201,044.
Claims priority of provisional application 61/725,153, filed on Nov. 12, 2012.
Claims priority of provisional application 61/676,859, filed on Jul. 27, 2012.
Claims priority of provisional application 61/589,920, filed on Jan. 24, 2012.
Claims priority of provisional application 61/578,712, filed on Dec. 21, 2011.
Prior Publication US 2022/0170938 A1, Jun. 2, 2022
Int. Cl. G01N 33/574 (2006.01); G01N 33/53 (2006.01); G01N 33/68 (2006.01); G16B 20/00 (2019.01); G16B 40/00 (2019.01)
CPC G01N 33/57423 (2013.01) [G01N 33/6893 (2013.01); G01N 33/53 (2013.01); G01N 33/6848 (2013.01); G16B 20/00 (2019.02); G16B 40/00 (2019.02)] 10 Claims
 
1. A method of analyzing a biological sample of a subject having a pulmonary nodule, comprising:
determining expression levels of a panel of proteins present in a blood sample obtained from the subject by an immunoassay, wherein the panel of proteins comprises LG3BP and C163A.